+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Regenerative Medicine Market by Technology and Geography - Forecast and Analysis 2020-2024 - Product Image

Regenerative Medicine Market by Technology and Geography - Forecast and Analysis 2020-2024

  • ID: 4990314
  • Report
  • April 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Allergan Plc
  • Amgen Inc.
  • Hitachi Chemical Co. Ltd.
  • Medtronic Plc
  • MiMedx Group Inc.
  • Smith & Nephew Plc
  • MORE
Global Regenerative Medicine Market 2020-2024

The publisher has been monitoring the global regenerative medicine market and it is poised to grow by USD 9.55 bn during 2020-2024, progressing at a CAGR of 20% during the forecast period. This report on the global regenerative medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases. In addition, increasing number of clinical trials is anticipated to boost the growth of the global regenerative medicine market as well.

Market Segmentation

The global regenerative medicine market is segmented as below:

Technology:
  • Cell and tissue-based
  • Gene therapy
Geographic segmentation:
  • North America
  • Europe
  • Asia
  • ROW
Key Trends for global regenerative medicine market growth

This study identifies increasing number of clinical trials as the prime reasons driving the global regenerative medicine market growth during the next few years.

Prominent vendors in global regenerative medicine market

The publisher provides a detailed analysis of around 25 vendors operating in the global regenerative medicine market, including some of the vendors such as Allergan Plc, Amgen Inc., Hitachi Chemical Co. Ltd., Integra LifeSciences Holdings Corp., Medtronic Plc, MiMedx Group Inc., Organogenesis Holdings Inc., Smith & Nephew Plc, Takeda Pharmaceutical Co. Ltd. and Zimmer Biomet Holdings Inc..

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Amgen Inc.
  • Hitachi Chemical Co. Ltd.
  • Medtronic Plc
  • MiMedx Group Inc.
  • Smith & Nephew Plc
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Technology
  • Market segments
  • Comparison by Technology placement
  • Cell and tissue-based - Market size and forecast 2019-2024
  • Gene therapy - Market size and forecast 2019-2024
  • Market opportunity by Technology
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
Drivers, Challenges, and Trends
  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Allergan Plc
  • Amgen Inc.
  • Hitachi Chemical Co. Ltd.
  • Integra LifeSciences Holdings Corp.
  • Medtronic Plc
  • MiMedx Group Inc.
  • Organogenesis Holdings Inc.
  • Smith & Nephew Plc
  • Takeda Pharmaceutical Co. Ltd.
  • Zimmer Biomet Holdings Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 4
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Market in focus
  • Parent market
  • Market characteristics
  • Product / Service portfolio of key vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2019 - 2024 ($ million)
  • Global market: Year-over-year growth 2019 - 2024 (%)
  • Five forces analysis 2019 & 2024
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2019
  • Technology placement - Market share 2019-2024 (%)
  • Comparison by Technology placement
  • Cell and tissue-based - Market size and forecast 2019-2024 ($ million)
  • Cell and tissue-based - Year-over-year growth 2019-2024 (%)
  • Gene therapy - Market size and forecast 2019-2024 ($ million)
  • Gene therapy - Year-over-year growth 2019-2024 (%)
  • Market opportunity by Technology
  • Customer landscape
  • Market share by geography 2019-2024 (%)
  • Geographic comparison
  • North America - Market size and forecast 2019-2024 ($ million)
  • North America - Year-over-year growth 2019-2024 (%)
  • Europe - Market size and forecast 2019-2024 ($ million)
  • Europe - Year-over-year growth 2019-2024 (%)
  • Asia - Market size and forecast 2019-2024 ($ million)
  • Asia - Year-over-year growth 2019-2024 (%)
  • ROW - Market size and forecast 2019-2024 ($ million)
  • ROW - Year-over-year growth 2019-2024 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers
  • Impact of challenges
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Allergan Plc - Overview (1/3)
  • Allergan Plc - Overview (2/3)
  • Allergan Plc - Overview (3/3)
  • Allergan Plc - Business segments
  • Allergan Plc - Key offerings
  • Allergan Plc - Key customers
  • Allergan Plc - Segment focus
  • Amgen Inc. - Overview (1/3)
  • Amgen Inc. - Overview (2/3)
  • Amgen Inc. - Overview (3/3)
  • Amgen Inc. - Business segments
  • Amgen Inc. - Key offerings
  • Amgen Inc. - Key customers
  • Amgen Inc. - Segment focus
  • Hitachi Chemical Co. Ltd. - Overview (1/3)
  • Hitachi Chemical Co. Ltd. - Overview (2/3)
  • Hitachi Chemical Co. Ltd. - Overview (3/3)
  • Hitachi Chemical Co. Ltd. - Business segments
  • Hitachi Chemical Co. Ltd. - Key offerings
  • Hitachi Chemical Co. Ltd. - Key customers
  • Hitachi Chemical Co. Ltd. - Segment focus
  • Integra LifeSciences Holdings Corp. - Overview (1/3)
  • Integra LifeSciences Holdings Corp. - Overview (2/3)
  • Integra LifeSciences Holdings Corp. - Overview (3/3)
  • Integra LifeSciences Holdings Corp. - Business segments
  • Integra LifeSciences Holdings Corp. - Key offerings
  • Integra LifeSciences Holdings Corp. - Key customers
  • Integra LifeSciences Holdings Corp. - Segment focus
  • Medtronic Plc - Overview (1/3)
  • Medtronic Plc - Overview (2/3)
  • Medtronic Plc - Overview (3/3)
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Key customers
  • Medtronic Plc - Segment focus
  • MiMedx Group Inc. - Overview (1/3)
  • MiMedx Group Inc. - Overview (2/3)
  • MiMedx Group Inc. - Overview (3/3)
  • MiMedx Group Inc. - Product and service
  • MiMedx Group Inc. - Key offerings
  • MiMedx Group Inc. - Key customers
  • MiMedx Group Inc. - Segment focus
  • Organogenesis Holdings Inc. - Overview (1/3)
  • Organogenesis Holdings Inc. - Overview (2/3)
  • Organogenesis Holdings Inc. - Overview (3/3)
  • Organogenesis Holdings Inc. - Business segments
  • Organogenesis Holdings Inc. - Key offerings
  • Organogenesis Holdings Inc. - Key customers
  • Organogenesis Holdings Inc. - Segment focus
  • Smith & Nephew Plc - Overview (1/3)
  • Smith & Nephew Plc - Overview (2/3)
  • Smith & Nephew Plc - Overview (3/3)
  • Smith & Nephew Plc - Business segments
  • Smith & Nephew Plc - Key offerings
  • Smith & Nephew Plc - Key customers
  • Smith & Nephew Plc - Segment focus
  • Takeda Pharmaceutical Co. Ltd. - Overview (1/3)
  • Takeda Pharmaceutical Co. Ltd. - Overview (2/3)
  • Takeda Pharmaceutical Co. Ltd. - Overview (3/3)
  • Takeda Pharmaceutical Co. Ltd. - Business segments
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Takeda Pharmaceutical Co. Ltd. - Key customers
  • Takeda Pharmaceutical Co. Ltd. - Segment focus
  • Zimmer Biomet Holdings Inc. - Overview (1/3)
  • Zimmer Biomet Holdings Inc. - Overview (2/3)
  • Zimmer Biomet Holdings Inc. - Overview (3/3)
  • Zimmer Biomet Holdings Inc. - Product and service
  • Zimmer Biomet Holdings Inc. - Key offerings
  • Zimmer Biomet Holdings Inc. - Key customers
  • Zimmer Biomet Holdings Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Allergan Plc
  • Amgen Inc.
  • Hitachi Chemical Co. Ltd.
  • Medtronic Plc
  • MiMedx Group Inc.
  • Smith & Nephew Plc
  • MORE
The publisher recognizes the following companies as the key players in the global regenerative medicine market: Allergan Plc, Amgen Inc., Hitachi Chemical Co. Ltd., Integra LifeSciences Holdings Corp., Medtronic Plc, MiMedx Group Inc., Organogenesis Holdings Inc., Smith & Nephew Plc, Takeda Pharmaceutical Co. Ltd. and Zimmer Biomet Holdings Inc.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of clinical trials."

According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Allergan Plc
  • Amgen Inc.
  • Hitachi Chemical Co. Ltd.
  • Integra LifeSciences Holdings Corp.
  • Medtronic Plc
  • MiMedx Group Inc.
  • Organogenesis Holdings Inc.
  • Smith & Nephew Plc
  • Takeda Pharmaceutical Co. Ltd.
  • Zimmer Biomet Holdings Inc.
Note: Product cover images may vary from those shown
Adroll
adroll